Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Low incidence of hepatic artery thrombosis after hepatic artery reconstruction in liver transplanation

O Kornasiewicz, Z Lewandowski, M Grąt, A Ścibisz, M Krawczyk

Ann Transplant 2009; 14(1): 43-43 :: ID: 880356

Abstract

Background: Hepatic artery thrombosis (HAT) remains an important cause
of graft loss after liver transplantation. HAT can be caused by technical, hemodynamic, or immunological factors. Bench reconstruction of anatomical variants of the hepatic artery is considered to be a major risk related to HAT. The purposes of the study were to analyse the infl uence of vascular reconstruction of the hepatic artery and its relation to HAT.
Material/Methods: We analysed, in retrospective study, 341 donors' forms
completed between January 2003 and December 2007. Vascular reconstruction was defined as an additional anastomosis between the donor's hepatic arteries which was required to obtain a full revascularisation of the graft.  Any incident of HAT was confi rmed by angiography or intraoperatively during re-transplanation. The Fishers Exact Test and 95% confidence intervals (CI) estimator were applied for statistical analysis.
Results: Of 341 grafts, hepatic artery anomalies were found in 92 cases
(26.9%). In 33 (35.8%) cases hepatic artery reconstruction was required. The HAT was diagnosed in 3% (1 of 33) with hepatic reconstruction group (CI 0.1%-15.8%) compared with 1.6% of grafts (5 of 208) which did not require hepatic reconstruction (p<0.45). There was one case of hepatic thrombosis (1 of 59) totalling 1.6% in the group with hepatic anomalies without  reconstruction (CI 0.04-9.1%)
Conclusions: A single hepatic reconstruction is a non significant factor for HAT. The hepatic artery anomalies do not increase the risk of HAT compared with the normal blood supply. The hepatic artery anomalies do not increase significantly the incidence of HAT compared to group of patient without anatomical abnormalities.

Keywords: Liver Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358